Clinical trial
Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who…
NCT00112567 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00112567 |
|---|---|
| Title | Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer |
| Official title | A Phase I/II Study of Total Body Irradiation, Thiotepa, and Fludarabine as Conditioning for Haploidentical CD34+ Purified Peripheral Blood Stem Cell Transplants |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | fludarabine phosphate, thiotepa, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 20 |
| Start date | Apr 1, 2003 |
| Completion | Jul 1, 2007 |
| First posted | Jun 3, 2005 |
| Last update posted | Sep 21, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: